Login

Financial Snapshot

Revenue
TTM
$31.28M
Gross Margin
TTM
77.47%
Net Income
TTM
-$2.665M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
62.36%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
-18.40M
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
$3.727M

Stock Price

Loading...
Market Cap: $27.307 Million

About Cryo-Cell International Inc

Cryo-Cell International (CCEL) is a cord blood and cord tissue banking company that collects, processes, and stores newborn stem cells for potential future medical use. The company makes money by charging families an upfront processing fee at the time of collection and recurring annual storage fees for the ongoing preservation of the biological material. The filing excerpts from the 10-K filed 2026-02-27 covering fiscal year ended November 30, 2025 identify the company as Cryo-Cell International, Inc. The business operates under a subscription-like storage model, where the recurring storage fee component provides a base of contractual, long-term revenue tied to the number of specimens under management. Switching costs are meaningful once a family has enrolled, as transferring stored biological samples is logistically complex and emotionally sensitive.

Revenue model
The filing excerpts reference revenue recognition as a noted accounting topic for fiscal years ended November 30, 2025 and 2024, consistent with a dual-stream model of one-time enrollment and processing fees plus recurring annual storage fees. Specific revenue figures are not supported by the provided excerpts.
Products and services
Cord blood banking, cord tissue banking, newborn stem cell processing and long-term cryogenic storage. Specific product names or additional service lines are not supported by the provided excerpts.
Customers and end markets
Expectant families seeking to preserve newborn cord blood and cord tissue stem cells for potential future medical or therapeutic use. Specific customer counts or end-market data are not supported by the provided excerpts.
Value-chain role
Direct-to-consumer biological sample collection, processing, and long-term cryogenic storage provider.
Geographic exposure
The company is identified as a U.S.-registered entity filing with the SEC. Specific geographic revenue breakdown or international operations are not supported by the provided excerpts.

Source: SEC 10-K, filed 2026-02-27

Industry: Services-Misc Health & Allied Services, NEC Peers: AKUMIN INC. Biodesix Inc Bimergen Energy Corp CVS Health Corp ENZO BIOCHEM INC InfuSystem Holdings Inc Talkspace Inc WeCapital Holdings, Inc. Psychemedics Corp

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support